Abstract. The objective of this study is to determine the in vitro cytotoxicity effect of chitosan hydrogel-based metronidazole on fibroblast. Chitosan hydrogel-based metronidazole(0.12%, 0.15%, 0.25%) and chitosan without metronidazole are made by dissolving lactic acid to reach a gel consistency, and then adding powdered metronidazole according to the concentration. 3T3 fibroblast cells were cultured in well mikroplate containing RPMI-1640 media inside an incubator. The cell viability tests were carried out using theMTT assay method and repeated five times. The colour degradation was read with a microplate reader. The mean viability of fibroblasts mixed with chitosan hydrogel-based metronidazole at concentration of 0.12%, 0.15%, and 0.25%, and chitosan without metronidazole were 96%, 93%, 91% and 98.8% respectively. ANOVA statistical test results for the 0.12% concentration group, where p < 0.05 represents the cell's viability, significantly differs from the results for the 0.15% and 0.25% concentration groups. Chitosan hydrogel-based metronidazole shows non toxic effects on fibroblast cells.
Introduction
Periodontitis is a severe stage of periodontal disease caused by alveolar bone resorption and loss of attachment to the periodontal ligament, which acts as a tooth support [1] . The main purpose of periodontal therapy to completely remove the bacterial plaque and remove the periodontal pocket from the granulation tissue for optimal healing [2] . Generally, biofilm associated with anaerobic bacteria is the main etiology of periodontal disease [3] . Conventional periodontal disease treatment consists of mechanical debridement to remove subgingival microbiota and calculus by means of scaling and root smoothness. Some case require additional chemical treatment. Maintaining proper oral hygiene at home is important [4, 5] . Chemical auxiliary treatment with antibiotic and antiseptic better for infection control and for controlling host tissue damage by using a host modulator [6] . Antibiotics may be given systemically and locally [7] . Introducing local antibiotics into the periodontal pocket is expected to achieve greater and stronger drug concentrations compared to systemic administration [8] .
Metronidazole is a broad-spectrum antimicrobial that combats protozoal and anaerobic bacterial infections [9, 10] . Today, metronidazole is one of the most widely used antimicrobials (with in an antibacterial compound) in the treatment of periodontal disease [11] .
Hydrogels are cross-linked, three dimensional hydrophilic polymeric networks that swell but not dissolve when brought into contact with water [12] . Using chitosan hydrogel as a drug-delivery vehicle has been widely described in certain types of literature [13] . Chitosan has advantages over other polysaccharides, as it is biocompatible, biodegradable and non-toxic [14] .
Research on the cytotoxicity effects of 3% chitosan hydrogel-based metronidazole (0.12%, 0.15%, and 0.25%) has never been done before. This research studies the cytotoxicity effects of chitosan hydrogel-based metronidazole, based on earlier research by Adha which studied the effectiveness of chitosan hydrogel-based metronidazole in inhibiting the growth of bacteria A. actinomycetemcomitans, P. gingivalis dan F. nucleatum invitro [15] .
Materials and Methods
The chitosan, provided by the Chemistry Departement, Universitas Sumatera Utara, was processed from shrimp shells. In this research, the first process used 3% chitosan hydrogel-based metronidazole (0.12%; 0.15%; 0.25%) and 3% chitosan hydrogel. Chitosan hydrogel-based metronidazole was made using methods from the formula described by Yellanki et al. [1] : Chitosan hydrogel (3%w/w) was prepared by continous manual mixing of 1.5 grams of chitosan with an adequate amount of lactic acid (2%). Metronidazole concentration of 0.12%, 0.15%, and 0.25% were dissolved in the chitosan hydrogel.
3T3 fibroblast cell-lines were cultured in microplates containing Rosewell Park Memorial Institute 1640 (RPMI-1640) media to obtain a cell/well density of 1x10 4 and incubated for 24 hours. After the media were washed with PBS and refreshed, 25 µl of each experimental hydrogels were then added to the microplate. This was followed by an incubation process at 37 o C. After 24 hours, the solution in well was flicked off and 50µl of MTT assay was added to each well. Five well for each of the 4 the experimental groups. Each group's wells were repeated five times, yielding a total of 100 wells.
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The percentage of cell ihibition was calculated by substracting the percentage of cell viability from 100. The Saphiro-Wilk normality test was conducted on the viability results, followed by the ANOVA test. The results were considered statistically significant when the p value was < 0.05
Results
The effects of cytotoxicity in chitosan hydrogel based metronidazole were assessed based on the absorbance values of 3T3 fibroblast cells. The crystalline purple was calculated using a microplate reader 24 hours after the test material was applied to the 3T3 fibroblast cells. The test material takes on a certain colour and the absorbance value measures the polarization of light absorbed by a particular material at a certain wavelength. Table 2 shows that the highest absorbance value on control cells containing fibroblast cells while the lowest on media control that contains RPMI media without 3T3 fibroblast cells. Absorbance values are required to calculate the percentage of cell viability. Table 3 shows chitosan hydrogel-based metronidazole 0.12%, 0.15%, 0.25% and 3% chitosan hidrogel seen that average percentage cell viability was > 90%. It shows that gel chitosan hydrogel -based metronidazole is not toxic. Thus, chitosan hydrogel-based metronidazole 0.12%, shows the highest viability compared with other concentrations. Table 4 shows that the percentage value of viability of all groups of test materials is normally distributed, therefore, in this study used ANOVA method to analyze the differences between groups of test materials statistically.
Based on ANOVA test, the 3T3 fibroblast viability of each tested material shows that there is a statistical difference where the p value is < 0.05, the number of fibroblast cell are low and the concentration of metronidazole used is a higher. 
Discussion
This study showed that chitosan hydrogel based metronidazole gel (0.12%, 0.15% and 0.25%) has an non-toxic effect on 3T3 fibroblast cells, as the average cell viability percentage is above 90%. Pursuant to ISO 10993-5 standards, percentages of cell viability above 80% are considered non-cytotoxic; between 80% to 60% are Advances in Health Sciences Research, volume 4 considered weak; viability percentages between 60% to 40% are considered moderate and viability percentages below 40% are considered strong [16] .
The highest viability percentage for 3T3 fibroblast cells (98.8%) was found in the 3% chitosan hydrogel group, followed by the 0.12% metronidazole gel (96%) and 0.15% metronidazole gel groups (92.6%). The lowest viability percentage (90.4%) was seen in the 0.25% metronidazole gel group. The viability percentage of 3T3 fibroblast cells with chitosan hydrogel-based metronidazole (0.12%, 0.15%, and 0.25%) and 3% chitosan hydrogel showed a significantly different result (p> 0.05). The highest percentage of 3T3 fibroblast cell viability was found in the 3% chitosan hydrogel application, with a mean of 98.8%, The lowest percentage of cell viability was found in the 0.25% chitosan hydrogel-based metronidazol, with a mean of 90.4%.
This study used 3% chitosan dissolved in 2% lactic acid. Based on Popa et al study states that higher concentration of chitosan will reduce the drug-releasing abilities. Research conducted by Yellanki et al. where 0.25% metronidazole dissolved in 2% lactic acid and 3% chitosan result showed a higher concentration of the drug, bioadhesive better and more controlled drug release [1, 13] .
Chitosan is a hydrophilic polysaccharide derived from the exoskeleton of crustaceans, such as shrimp, crab and other sea crustaceans [17] . This study used chitosan from crabs. Chitosan is a non-toxic, biocompatible and inexpensive substance that is effective in releasing in the drug [18] .
Grobler et al. says that 3T3 fibroblast cells have been widely used for many years as standard in cytotoxicity tests because they have similarities with human fibroblasts of human tooth pulp. Fibroblasts are the main cells in connective tissue, which is located in the lamina propria of the oral mucosa and the gingiva. The observation of viability in cultured fibroblast cell can be used as an indicator to determine the effect of concentration and exposure to a substance, including the cytotoxicity effects [18] .
The aboved discussion show that chitosan hydrogel-based metronidazole (0.12%, 0.15% and 0.25%) did not show cytotoxic properties in 3T3 fibroblast cells. This is a basis for further research, because chitosan hydrogel-based metronidazole may later be used clinically as a supportive periodontal treatment.
Conclusions
Chitosan hydrogel-based metronidazole 0.12%, 0.15%, 0.25% and 3% chitosan hidrogel shows a higher viability percentage and is not cytotoxic in 3T3 fibroblast cell. 3% chitosan hydrogel shows good biocompatibility characteristics on 3T3 fibroblast cell.
